Bank of America analysts on Friday said Novo Nordisk may miss first-quarter expectations, as sales of its blockbuster Wegovy ...
Novo Nordisk shares rose Monday as the company said it would present new data on the ability of semaglutide, the active ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback